2012

1. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma

   Oncology, Vol. 82, Núm. 1, pp. 35-40

2. Predicting response to therapy in chronic hepatitis C: An approach combining interleukin-28B gene polymorphisms and clinical data

   Journal of Gastroenterology and Hepatology (Australia), Vol. 27, Núm. 2, pp. 279-285

3. Relation of IL28b gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease

   PLoS ONE, Vol. 7, Núm. 5